Option Care Health, INC

Option Care Health announced its second quarter 2026 financial results, reporting increased net revenue, GAAP net income, and diluted EPS, alongside updated full-year guidance.

Option Care Health shareholders re-elected all nine director nominees and ratified the appointment of KPMG LLP as the company's independent auditor.

Option Care Health, Inc. management is participating in the Bank of America Health Care Conference on May 12, 2026, presenting an investor deck.

Option Care Health, Inc. reports the departure of its Chief Growth Officer, Christopher L. Grashoff, effective May 8, 2026, with separation benefits contingent on a general release of claims.

Option Care Health reported mixed first quarter 2026 financial results, with revenue up slightly but Adjusted EBITDA down, leading to an adjustment in full-year revenue guidance.

Option Care Health has entered into a Fifth Amendment to its credit agreement, increasing its revolving credit commitments by $450 million to a total of $850 million.

Option Care Health reported Q2 2026 results with increased net revenue driven by its acute portfolio, though gross profit margin saw a slight decrease due to shifts in therapy mix.

Option Care Health, Inc. reported increased net revenue for the third quarter and first nine months of 2025, driven by organic growth and an acquisition, alongside a significant debt refinancing and continued share repurchases.

Option Care Health, Inc. announced robust revenue growth for the second quarter and first half of 2025, driven by organic expansion and a recent acquisition, though profitability margins experienced a decline.

Option Care Health's Q1 2025 net revenue increased by 16.3% year-over-year, driven by organic growth in both acute and chronic therapies.

Option Care Health's third quarter 2024 results show a revenue increase driven by organic growth in chronic therapies, despite a slight decrease in gross profit margin.

Option Care Health's second quarter 2024 results show revenue growth driven by chronic therapies, despite a slight decrease in gross profit margin.

Option Care Health, a leading provider of home and alternate site infusion services, reported a 13% increase in net revenue to $5.65 billion for the fiscal year ended December 31, 2025, despite a slight dip in net income.

Option Care Health's FY2024 revenue increased by 16.2%, driven by organic growth in both acute and chronic therapies, though gross profit margin declined due to therapy mix and procurement dynamics.

Option Care Health's 2023 10-K filing reveals increased revenue and net income driven by organic growth and strategic initiatives, despite challenges in the competitive healthcare landscape.

Prateek Bhatia, EVP Sp Sales & Solutions at Option Care Health, Inc., reported the acquisition of 16,386 and 23,409 shares of common stock on July 6, 2026, through a Rule 10b5-1(c) plan.

Option Care Health director Elizabeth Bierbower was granted 8,997 restricted stock units valued at $200,000.

Director Natasha Deckmann acquired 9,841 shares of Option Care Health, Inc. through restricted stock unit grants.

Director Harry M. Jansen Kraemer Jr. acquired 21,076 shares of Option Care Health, Inc. through restricted stock unit grants.

Director R. Carter Pate received an award of 8,997 restricted stock units valued at $200,000.

Director Timothy P. Sullivan acquired 13,833 shares of Option Care Health, Inc. through restricted stock unit grants.

Option Care Health, Inc. has released its 2026 Proxy Statement, detailing proposals for director elections, auditor ratification, and executive compensation, alongside a review of its 2025 performance and corporate governance.

Option Care Health, Inc. has filed a definitive proxy statement with the SEC.

Option Care Health's 2025 proxy statement highlights proposed governance enhancements, executive compensation adjustments based on stockholder feedback, and director nominations.

Option Care Health, Inc. has filed a definitive proxy statement with the SEC, soliciting material under Exchange Act Rule 240.14a-12.

Option Care Health's definitive proxy statement highlights the company's 2023 performance, governance updates, and director nominees for the upcoming annual meeting.

FMR LLC, through its subsidiaries, has disclosed beneficial ownership of 4.1% of Option Care Health Inc.'s common stock as of March 31, 2026.

Vanguard Capital Management reports beneficial ownership of over 8.2 million shares, representing 5.25% of Option Care Health Inc.'s common stock.

Vanguard Portfolio Management has reported beneficial ownership of 5.24% of Option Care Health Inc.'s common stock as of March 31, 2026.

The Vanguard Group reports zero beneficial ownership in Option Care Health Inc. following an internal realignment.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 5.3% in Option Care Health Inc., totaling 8,658,743.98 common shares.

Wellington Management Group and its affiliates report an 8.1% beneficial ownership stake in Option Care Health, Inc. common stock.